In the podcast’s season finale, learn how we're making progress, challenging harmful systems, and creating real solutions in the push to eliminate gender-based violence.
One woman dies every nine days in Australia from domestic violence. In this “What Happens Next?” episode, leading experts examine the drivers behind this national emergency.
Discover the urgent climate challenges facing the Indo-Pacific and the power of storytelling to drive meaningful climate action in this new “What Happens Next?” episode.
While AI and robotics reshape our reality, experts explore how these emerging tools could be used to create a more equitable future – from healthcare breakthroughs to Indigenous-led innovation.
Scientists have utilised AI to predict T cell receptors, advancing personalised medicine, and boosting immunotherapy and vaccine development.
In the season nine premiere of Monash’s podcast, learn how AI, deepfakes and humanoid robots are transforming human interaction and our perception of reality.
Common steroid treatments for the autoimmune disease lupus can cause as many problems as they solve, but researchers are close to finding a viable alternative.
For the first time, researchers have used blood tests to identify concussion caused by domestic violence, including some patients who also experienced non-fatal strangulation.
Research shows the vast majority of Australians aren’t opposed to the government introducing a range of stronger conservation-related policies.
The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
A team of scientists has developed an imaging technique to earlier detect abnormal collagen deposits in the heart, which causes a condition known as diffuse cardiac fibrosis.
New research reveals how water containing the antidepressant Prozac affects male guppies, raising concerns about the health of aquatic ecosystems exposed to pharmaceutical pollution.
Businesses are facing increasing pressure to address major global challenges such as climate change, poverty, and healthcare access. But can companies really make a difference while still turning a profit?
The issue of medicine-related harm is immense, and how to tackle it is an area of growing interest to governments and healthcare systems alike.
In a world first, researchers are harnessing data science to describe and predict when resistance to antibiotics will emerge during treatment for a bacterial infection.
The Sensory Science concept grew from the aim to “bring the beauty of the microscope to life for the low-vision and blind community”, and make science more accessible.
The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
Researchers have uncovered two sticks in fireplaces inside a southeast Australia cave that provide profound insights into the rich heritage of local Indigenous people and curse-making practices.
Fifteen years of patient data has revealed an important link between hospital-acquired infections and seizure and epilepsy onset.
A blood test that accurately detects the ongoing effects of sport-related concussion has the potential to help pinpoint when a player can safely return.
Nitazenes can be up to 50 times stronger than fentanyl. They’re not yet common in Australia, so now’s the time to implement policies to reduce their harm and limit their uptake.
Menopause has become a hot health topic, with experts debating the latest treatments and what’s appropriate for women who need them.
Some women who use drugs like Ozempic have reported unexpected pregnancies. What’s going on?
Dummy text
